Lantheus Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
The following table summarizes information regarding our significant leased and owned properties, as of December 31, 2025:
| Location | Purpose | Square Footage | Ownership | Lease Term End |
|---|---|---|---|---|
| United States | ||||
| North Billerica, Massachusetts | Manufacturing, Laboratory, Mixed Use and Other Office Space | 354,000 | Owned (1) | N/A |
| Bedford, Massachusetts | Executive Offices, Laboratory, Office Space | 88,181 | Leased | February 2040 |
| Bedford, Massachusetts | Office Space | 41,229 | Leased | July 2028 |
| New York, New York | Office Space | 26,558 | Leased (2) | September 2030 |
| Springfield, New Jersey | Manufacturing | 13,079 | Owned | N/A |
| Germany | ||||
| Berlin | Office Space | 11,657 | Leased | December 2031 |
(1)
On January 1, 2026, we sold our single-photon emission computerized tomography (“SPECT”) business to SHINE Technologies, LLC. (“SHINE”). As a result of the sale, SHINE received 292,215 square feet of the North Billerica, Massachusetts campus that manufactures the SPECT products.
(2)
On October 11, 2021, we entered into an agreement to sublease our office space at the World Trade Center in New York City to an unrelated third party.
We believe all of these facilities are well-maintained and suitable for the office, manufacturing or warehouse operations conducted in them and provide adequate capacity for current and foreseeable future needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.